Skip to content

Lifecore Biomedical, Inc. LFCR Cash Flow Statement

Q4 '26Q2 '26Q4 '25Q3 '25Q2 '25
-$14.98M-1,206%-$9.99M-52.0%-$1.15M-$14.77M-194%-$6.57M-146%
$2.31M+20.7%$1.98M-3.1%$1.91M-5.0%$2.08M+3.5%$2.04M+15.7%
$1.7M-6.4%$2.39M-29.1%$1.82M+13.6%$2.55M+70.9%$3.37M+114%
$4.7M$1.76M+129%$1.2M+185%-$6.14M-577%
$1.12M-46.7%$1.74M-28.8%$2.1M-22.7%$5.46M-14.3%$2.44M-42.7%
-$1.12M+46.7%-$1.74M+28.8%-$2.1M+22.7%$1.54M+124%-$2.44M+42.7%
$36.4M$12.1M$33.89M+17,461%
-$256K-$1.39M-111%$0-$6.78M-189%$12.52M
$3.33M-$1.36M-135%-$4.04M-2,630%$3.94M+173%
$3.58M$25K+100%-$4.26M+45.3%-$8.58M-189%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Lifecore Biomedical, Inc. generate?
Lifecore Biomedical, Inc. (LFCR) generated $1.5M in operating cash flow over the trailing twelve months.
What is Lifecore Biomedical, Inc.'s free cash flow?
After $10.4M of capital expenditures, Lifecore Biomedical, Inc.'s free cash flow was -$9.2M over the trailing twelve months, up 67.2% year over year.
Where does Lifecore Biomedical, Inc.'s cash flow data come from?
Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.